Activity Details

1.25 AMA PRA Category 1 Credit(s)™ /
Released: September 30, 2020
Expires: September 29, 2021
75 minutes to complete

Accredited By

This continuing medical education activity is provided by

Target Audience

The intended audience for this activity is gynecologists, obstetricians, family practice physicians, internists, and other health care professionals involved in the management of patients at risk for cardiovascular disease (CVD).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Describe traditional and female-predominant factors that contribute to CVD risk in women.
  • Outline available screening tools and guidelines to identify women with elevated CVD risk.
  • Review available clinical evidence to select treatment for patients who may benefit from reduction of LDL cholesterol for decreased risk of adverse CVD outcomes.
  • Assess evidence-based strategies to reduce triglyceride levels in patients who may benefit from further CVD risk reduction.
  • Define approaches to improve patient communication and education to increase awareness of CVD risks in women and the importance of interventions to reduce risk.

Activity Description

Cardiovascular disease is the leading cause of death globally, and women are disproportionately affected, with higher morbidity and mortality rates than men. This trend has continued despite recent advances in awareness campaigns, gender-based guidelines, as well as available therapies. In the United States, CVD accounts for approximately 1 of every 5 female deaths, with almost 300,000 deaths in women each year. In addition to traditional cardiovascular risk factors, women often carry several nontraditional risk factors, many of which are related to pregnancy, hormonal influences, or comorbid disorders. Furthermore, women are less likely to receive guideline-recommended diagnostic testing and therapies. The faculty of this CME activity will address CVD risk factors, appropriate screening, as well as recent advances in management to improve outcomes and reduce CVD mortality.


Defining and Recognizing Cardiovascular Disease Risk in Women
Martha Gulati, MD, MS, FACC, FAHA, FASPC

Reducing ASCVD Risk With Further Advances in Lipid-Lowering Therapy

Clinical Cases
Martha Gulati, MD, MS, FACC, FAHA, FASPC, and Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC


Activity Co-Chairs:

Martha Gulati, MD, MS, FACC, FAHA, FASPC
Professor of Medicine
Chief of Cardiology, University of Arizona College of Medicine – Phoenix
Editor-in-Chief, CardioSmart for the American College of Cardiology
Phoenix, AZ

Disclosure: No relevant financial relationships to disclose.

Associate Professor of Medicine & Epidemiology
Director of Women’s Cardiovascular Health
Associate Director of Preventive Cardiology
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins University School of Medicine
Baltimore, MD

Disclosure: No relevant financial relationships to disclose.

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to disclose.

Ronald A. Codario, Jr., MD
Disclosure: No relevant financial relationships to disclose.

Vindico Medical Education Staff:
Disclosure: No relevant financial relationships to disclose. 

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Conflict of Interest Policy/Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, faculty, and reviewers involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above which is accurate at the time of content development.

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Vindico Medical Education designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine's (ABIM) MOC program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Instructions for Receiving Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 80% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Statement of Commercial Support

This activity is supported by an educational grant from Amarin Pharma Inc.

Disclaimer Statement/Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.